ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.

March 11, 2005

Austria Has highest Cancer Rate, Little NCI Support

June 17, 1977

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

Prostate Ultrasound Markers Concepts Approved by BSC

October 3, 1986

White House Picks Harold Varmus For NCI

May 21, 2010

In Brief: Shingleton Probably Replacement For Marks On Panel; Connie Henke Heads Oncology Nurses

June 8, 1979